gilead - BingNewshttp://www.bing.com/news/search?q=gilead&FORM=BNFD&format=rssSearch resultshttp://www.bing.com/rsslogo.gifgileadhttp://www.bing.com/news/search?q=gilead&FORM=BNFD&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.Gilead's drug wins first-ever US approval for deadly liver infectionhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11314f19dc45989b888bd3d5f24fed&url=https%3a%2f%2fwww.msn.com%2fen-us%2fmoney%2fgeneral%2fgilead-s-drug-wins-first-ever-us-approval-for-deadly-liver-infection%2far-AA23PSc5&c=17603192785602836237&mkt=en-usMay 22 (Reuters) - Gilead Sciences said on Friday that its experimental drug for a rare and deadly liver infection that had no approved treatment has won U.S. approval. Shares of the company were up ...Fri, 22 May 2026 12:15:56 GMTReuters on MSNhttp://www.bing.com/th?id=ONUT.YHTPfEZ_tjEGcbduVCoo7w&pid=Newsw={0}&h={1}&c=14800527US FDA approves Gilead's drug for deadly liver infectionhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11314f19dc45989b888bd3d5f24fed&url=https%3a%2f%2fwww.aol.com%2farticles%2fus-fda-approves-gileads-drug-180609000.html&c=16636550781260774758&mkt=en-usFood and Drug Administration ‌said on Friday it ‌approved Gilead Sciences' drug for a ​rare and deadly liver infection that previously had no approved treatment options. The health regulator ‌cleared ...Fri, 22 May 2026 18:06:00 GMTAOLhttp://www.bing.com/th?id=ONUT.5LYUkcw96l0x3DpPLXoySQ&pid=Newsw={0}&h={1}&c=14800527Gilead Sciences completes Tubulis acquisition for $5bnhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11314f19dc45989b888bd3d5f24fed&url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fgilead-sciences-completes-tubulis-acquisition-for-5bn%2far-AA23Q2qf&c=1612423811097129723&mkt=en-usGilead acquired all outstanding equity of Tubulis for $3.15bn upfront, plus up to $1.85bn in milestone payments.Fri, 22 May 2026 04:19:52 GMTPharmaceutical Technology on MSNhttp://www.bing.com/th?id=ONUT.EK0jk5itIBKJdOMehpOtOg&pid=Newsw={0}&h={1}&c=141440821Gilead Gets Positive Opinion From European Regulators on Breast-Cancer Treatmenthttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11314f19dc45989b888bd3d5f24fed&url=https%3a%2f%2fwww.marketwatch.com%2fstory%2fgilead-gets-positive-opinion-from-european-regulators-on-breast-cancer-treatment-f9788fdc&c=8647925321594200390&mkt=en-usGilead Sciences received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency recommending the marketing authorization of its Trodelvy drug to ...Fri, 22 May 2026 14:53:00 GMTMarketWatchGilead Sciences Completes Acquisition of Tubulis Further Strengthening Oncology Portfoliohttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11314f19dc45989b888bd3d5f24fed&url=https%3a%2f%2flasvegassun.com%2fnews%2f2026%2fmay%2f21%2fgilead-sciences-completes-acquisition-of-tubulis-f%2f&c=6912485321120795047&mkt=en-usGilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of its previously announced acquisition of Tubulis GmbH, a private Germany-based, clinical-stage biotechnology company ...Thu, 21 May 2026 13:11:00 GMTLas Vegas SunAstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datrowayhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11314f19dc45989b888bd3d5f24fed&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fastrazeneca-daiichi-beat-gilead-first-line-tnbc-fda-nod-datroway&c=2610486707108000399&mkt=en-usThe TROP2 battle in first-line triple-negative breast cancer has officially kicked off. | A three-way battle among TROP2 ADCs in first-line triple-negative breast cancer is forming as AstraZeneca and ...Fri, 22 May 2026 08:32:00 GMTFierce Pharmahttp://www.bing.com/th?id=ONUT.MxO25PNJvfC-cJgJ2ZZTgQ&pid=Newsw={0}&h={1}&c=1440002249Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitorshttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11314f19dc45989b888bd3d5f24fed&url=https%3a%2f%2fwww.rutlandherald.com%2fnews%2fbusiness%2fgilead-receives-chmp-positive-opinion-for-trodelvy-in-first-line-metastatic-triple-negative-breast-cancer%2farticle_87d699b4-66b4-56f7-9cc9-2f93d06d5e24.html&c=11411485420599891661&mkt=en-usGilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending ...Fri, 22 May 2026 03:47:00 GMTRutland HeraldGilead Sciences Gets FDA Green Light for Chronic HDV Drughttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11314f19dc45989b888bd3d5f24fed&url=https%3a%2f%2fwww.marketwatch.com%2fstory%2fgilead-sciences-gets-fda-green-light-for-chronic-hdv-drug-45ff5919&c=11256886572141788092&mkt=en-usGilead Sciences received accelerated approval for a chronic hepatitis delta virus treatment from the Food and Drug Administration. The FDA said the Hepcludex treatment, known also as bulevirtide-gmod, ...Fri, 22 May 2026 14:54:00 GMTMarketWatchGilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collabhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11314f19dc45989b888bd3d5f24fed&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fgilead-pledges-400k-ambiosome-doses-fight-visceral-leishmaniasis-expanded-who-collab&c=12053097821610956371&mkt=en-usGilead Sciences and the World Health Organization (WHO) are doubling down on a pact to eliminate deadly parasitic disea | Gilead’s five-year contract with the WHO is centered on providing AmBisome to ...Thu, 21 May 2026 08:18:00 GMTFierce Pharmahttp://www.bing.com/th?id=ONUT.m2G-C-7VjD30S2LeXfwLMg&pid=Newsw={0}&h={1}&c=141280730Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Nowhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11314f19dc45989b888bd3d5f24fed&url=https%3a%2f%2f247wallst.com%2finvesting%2f2026%2f05%2f21%2fforget-moderna-this-biotech-juggernaut-is-a-way-better-buy-right-now%2f&c=16969789408277169703&mkt=en-usModerna (NASDAQ:MRNA | MRNA Price Prediction) is back in the headlines after ripping 63.17% higher year to date on a surprise Q1 revenue triple and renewed pipeline excitement. But the underlying ...Thu, 21 May 2026 06:36:00 GMT24/7 Wall St.7 months after last layoffs, Bay Area biotech giant Gilead does another roundhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a11314f19dc45989b888bd3d5f24fed&url=https%3a%2f%2fwww.sfgate.com%2ftech%2farticle%2fgilead-layoffs-bay-area-22245159.php&c=13457757568770173720&mkt=en-usOnly seven months after its last major round of Bay Area layoffs, biotech company Gilead Sciences is laying off 108 workers from its Redwood City offices.Wed, 06 May 2026 15:40:00 GMTSFGATE